• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Chimerix, Inc. - Common Stock (NQ: CMRX )

    3.220 -0.120 (-3.59%)
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Chimerix, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 Next >
    Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024
    From Chimerix, Inc.
    Via GlobeNewswire
    Chimerix Appoints Lisa Decker to Board of Directors
    Seasoned Industry Executive Brings More Than 25 Years of Leadership and Business Development Experience 
    From Chimerix, Inc.
    Via GlobeNewswire
    Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer
    Proven Leader Brings More Than 25 Years of Financial Experience 
    From Chimerix, Inc.
    Via GlobeNewswire
    Earnings Outlook For Chimerix
    Via Benzinga
    4 Analysts Have This to Say About Chimerix
    Via Benzinga
    A Look Into Healthcare Sector Value Stocks
    Via Benzinga
    Chimerix Earnings Preview
    Via Benzinga
    Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From Chimerix, Inc.
    Via GlobeNewswire
    Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial Officer
    Seasoned Executive Brings More Than 25 Years of Industry Leadership Experience in Oncology Commercialization and Corporate Business Development 
    From Chimerix, Inc.
    Via GlobeNewswire
    Chimerix Reports Third Quarter 2023 Financial Results and Provides Operational Update
    From Chimerix, Inc.
    Via GlobeNewswire
    Chimerix to Report Third Quarter 2023 Financial Results and Provide an Operational Update on November 2, 2023
    From Chimerix, Inc.
    Via GlobeNewswire
    NetSol Technologies And 2 Other Stocks Under $2 Insiders Are Buying
    The Dow Jones closed lower by around 388 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Overview Of Value Stocks In The Healthcare Sector
    Via Benzinga
    Chimerix to Participate in Upcoming Investor Conferences
    From Chimerix, Inc.
    Via GlobeNewswire
    Chimerix Announces Data Highlighting Clinical Efficacy and Molecular Mechanisms of Response to ONC201 Treatment of H3 K27M-Mutant Diffuse Midline Gliomas Published in "Cancer Discovery"
    From Chimerix, Inc.
    Via GlobeNewswire
    CMRX Stock Warning! Smart Biotech Investors Will Avoid Chimerix Like the Plague.
    CMRX stock may seem like a high-risk, high-potential play, but it makes sense why the market has bid down this biotech. 
    Via InvestorPlace
    Chimerix Reports Second Quarter 2023 Financial Results and Provides Operational Update
    From Chimerix, Inc.
    Via GlobeNewswire
    7 Millionaire-Maker Penny Stocks to Buy Before the Window Closes
    Although speculative trades are not for everyone, these millionaire-maker penny stocks could turn small bets into big returns. 
    Via InvestorPlace
    Chimerix to Report Second Quarter 2023 Financial Results and Provide an Operational Update on August 3, 2023
    From Chimerix, Inc.
    Via GlobeNewswire
    7 Small-Cap Stocks to Buy Before the Breakout
    If you don’t mind the extreme risks involved, growth investors should target these ideas for best small cap stocks to buy. 
    Via InvestorPlace
    Why These 7 Stocks Are the Best Ways to Play Biotech Right Now
    With biotech stocks offering myriad viable opportunities irrespective of broader conditions, this sector is worth a closer look. 
    Via InvestorPlace
    Chimerix Announces Promotion of Michael T. Andriole to President and Chief Executive Officer
    From Chimerix, Inc.
    Via GlobeNewswire
    7 Deeply Undervalued Growth Stocks to Buy in June
    Investors may see significant rewards betting on these best undervalued growth stocks for June. 
    Via InvestorPlace
    Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference
    From Chimerix, Inc.
    Via GlobeNewswire
    Chimerix to Participate in Cancer Moonshot Brain Cancers Forum on Glioblastoma (GBM) and Diffuse Intrinsic Pontine Glioma (DIPG) at White House
    Forum Aim is to Share Progress and Spur Actions to Advance the Field 
    From Chimerix, Inc.
    Via GlobeNewswire
    Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2023
    Via Benzinga
    Chimerix Reports First Quarter 2023 Financial Results and Provides Operational Update
    From Chimerix, Inc.
    Via GlobeNewswire
    Chimerix to Report First Quarter 2023 Financial Results and Provide an Operational Update on May 4, 2023
    From Chimerix, Inc.
    Via GlobeNewswire
    Chimerix Announces Presentation of Multiple Imipridone Datasets at American Association for Cancer Research Annual Meeting
    From Chimerix, Inc.
    Via GlobeNewswire
    7 Thrilling Biotech Stocks for Aggressive Investors to Buy
    Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own. 
    Via InvestorPlace
    < Previous 1 2 3 4 5 6 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.